FDA Approves Praxbind to Reverse Anticoagulant PradaxaFDA Approves Praxbind to Reverse Anticoagulant Pradaxa

The FDA has approved Praxbind, a drug designed to rapidly reverse the anticoagulant effects of Pradaxa. FDA Approvals
Source: Medscape Neurology and Neurosurgery Headlines - Category: Neurology Tags: Neurology & Neurosurgery News Alert Source Type: news